27th Feb 2024 A plain language summary looking at nivolumab that is given after stage 2B/2C melanoma is removed by surgery
25th Jan 2024 GATHER1 and GATHER2 studies: a plain language summary looking at whether avacincaptad pegol works and is safe in people with geographic atrophy
22nd Jan 2024 Two different concentrations of GP2017 (a biosimilar medicine) are associated with similar drug levels in the body- a plain language summary
22nd Jan 2024 A plain language summary of epicutaneous immunotherapy with Viaskin™ Peanut in toddlers
6th Oct 2023 The TOPAZ-1 study: a plain language summary describing durvalumab and chemotherapy for advanced biliary tract cancer
22nd Sep 2023 A plain language summary of the HIMALAYA study which looked at tremelimumab and durvalumab for unresectable hepatocellular carcinoma
11th Jul 2023 Plain Language Summary: the CARTITUDE-1 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma
2nd Jun 2023 Plain Language Summary: comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms
12th Apr 2023 Plain Language Summary: the CheckMate 274 study, treatment of muscle-invasive urothelial cancer with nivolumab